Antibody responses to four Haemophilus influenzae type b conjugate vaccines. 1991

H Käyhty, and J Eskola, and H Peltola, and P R Rönnberg, and E Kela, and V Karanko, and L Saarinen
Department of Bacteriology, National Public Health Institute, Helsinki, Finland.

Serum antibody responses to four Haemophilus influenzae type b capsular polysaccharide-protein conjugate vaccines (PRP-D, HbOC, C7p, and PRP-T) were studied and compared in 175 infants, 85 adults and 140 2-year-old children. Antibodies to the H influenzae type b polysaccharide vaccines were determined with a Farr-type radioimmunoassay. The infants received two doses of vaccine at the ages of 4 and 6 months. After the first dose of vaccine, the geometric mean antibody concentration measured at the age of 6 months was 0.09 to 0.10 mg/L, only marginally higher than that measured before immunization in all infants who had received PRP-D, HbOC, or C7p but increased to 0.82 mg/L in those who had received PRP-T. One month after the second dose, the geometric mean antibody concentration was increased in all vaccine groups. No significant differences were noted between recipients of HbOC, C7p, or PRP-T (geometric mean antibody concentrations, 4.32, 3.10, and 6.10 mg/L, respectively), whereas the PRP-D recipients had a significantly lower geometric mean antibody concentration (0.63 mg/L). In contrast, PRP-D, HbOC, C7p, and PRP-T were all highly immunogenic in adults, with no differences noted among them. The 2-year-old children also responded to one dose of these vaccines with a high antibody concentration.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004168 Diphtheria Toxoid The formaldehyde-inactivated toxin of Corynebacterium diphtheriae. It is generally used in mixtures with TETANUS TOXOID and PERTUSSIS VACCINE; (DTP); or with tetanus toxoid alone (DT for pediatric use and Td, which contains 5- to 10-fold less diphtheria toxoid, for other use). Diphtheria toxoid is used for the prevention of diphtheria; DIPHTHERIA ANTITOXIN is for treatment. Diphtheria Vaccine,Toxoid, Diphtheria,Vaccine, Diphtheria
D005260 Female Females
D006192 Haemophilus Infections Infections with bacteria of the genus HAEMOPHILUS. Hemophilus Infections,Haemophilus influenzae Infection,Haemophilus influenzae Type b Infection,Hib Infection,Infections, Haemophilus,Infections, Hemophilus,Haemophilus Infection,Haemophilus influenzae Infections,Hemophilus Infection,Hib Infections,Infection, Haemophilus,Infection, Haemophilus influenzae,Infection, Hemophilus,Infection, Hib
D006193 Haemophilus influenzae A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII. Bacterium influenzae,Coccobacillus pfeifferi,Haemophilus meningitidis,Hemophilus influenzae,Influenza-bacillus,Mycobacterium influenzae
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies

Related Publications

H Käyhty, and J Eskola, and H Peltola, and P R Rönnberg, and E Kela, and V Karanko, and L Saarinen
January 1995, Pharmaceutical biotechnology,
H Käyhty, and J Eskola, and H Peltola, and P R Rönnberg, and E Kela, and V Karanko, and L Saarinen
October 2004, Immunology,
H Käyhty, and J Eskola, and H Peltola, and P R Rönnberg, and E Kela, and V Karanko, and L Saarinen
November 1992, The Annals of pharmacotherapy,
H Käyhty, and J Eskola, and H Peltola, and P R Rönnberg, and E Kela, and V Karanko, and L Saarinen
December 1990, Pediatric annals,
H Käyhty, and J Eskola, and H Peltola, and P R Rönnberg, and E Kela, and V Karanko, and L Saarinen
January 1993, Vaccine,
H Käyhty, and J Eskola, and H Peltola, and P R Rönnberg, and E Kela, and V Karanko, and L Saarinen
February 1992, The Journal of pediatrics,
H Käyhty, and J Eskola, and H Peltola, and P R Rönnberg, and E Kela, and V Karanko, and L Saarinen
October 1994, JAMA,
H Käyhty, and J Eskola, and H Peltola, and P R Rönnberg, and E Kela, and V Karanko, and L Saarinen
February 1995, The Journal of pediatrics,
H Käyhty, and J Eskola, and H Peltola, and P R Rönnberg, and E Kela, and V Karanko, and L Saarinen
August 1996, Archives of disease in childhood,
H Käyhty, and J Eskola, and H Peltola, and P R Rönnberg, and E Kela, and V Karanko, and L Saarinen
January 2003, The Cochrane database of systematic reviews,
Copied contents to your clipboard!